Nutex Health Return on Equity

Nutex Health (NUTX) currently reports a ROE of 21.8%. That is above the Consumer Staples sector average of 14.41%. Use the charts on this page to explore Nutex Health's ROE history and peer comparisons.

Nutex Health's ROE of 21.8% is higher than the Consumer Staples sector average of 14.41%. That is roughly 51.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Nutex Health's current 21.8% should be judged against Consumer Staples norms (sector average: 14.41%) and against NUTX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 21.8%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Staples average is 14.41%. From there, open related valuation or income-statement pages for Nutex Health, and consider following NUTX for alerts when major investors trade the stock.

Nutex Health is classified in the Consumer Staples sector. On ROE, it currently shows 21.8% versus a sector average near 14.41%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing NUTX with unrelated industries.